CISTERNINO, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 4.514
EU - Europa 3.241
AS - Asia 2.389
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
AF - Africa 4
SA - Sud America 4
Totale 10.163
Nazione #
US - Stati Uniti d'America 4.455
CN - Cina 2.164
UA - Ucraina 818
IE - Irlanda 709
SE - Svezia 432
FI - Finlandia 431
DE - Germania 419
IT - Italia 188
SG - Singapore 167
GB - Regno Unito 145
CA - Canada 55
FR - Francia 35
IN - India 17
BE - Belgio 16
ES - Italia 11
KR - Corea 9
PL - Polonia 9
EU - Europa 6
NL - Olanda 6
JO - Giordania 5
JP - Giappone 5
RU - Federazione Russa 5
AU - Australia 4
CH - Svizzera 4
LK - Sri Lanka 4
TR - Turchia 4
BG - Bulgaria 3
IQ - Iraq 3
MX - Messico 3
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
LV - Lettonia 2
MU - Mauritius 2
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
GR - Grecia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VN - Vietnam 1
Totale 10.163
Città #
Chandler 1.014
Jacksonville 1.013
Dublin 709
Nanjing 681
Boardman 301
Nanchang 270
Ashburn 266
Princeton 205
Shenyang 193
Lawrence 188
Hebei 183
Wilmington 177
Changsha 165
Jiaxing 159
Medford 132
Beijing 116
Tianjin 115
Singapore 111
Ann Arbor 93
Hangzhou 92
Woodbridge 62
Helsinki 53
Toronto 50
Norwalk 36
Falls Church 33
Milan 31
Shanghai 30
New York 28
Dearborn 21
Kunming 20
Houston 15
Los Angeles 15
Seattle 15
Brussels 14
Des Moines 14
Jinan 14
Zhengzhou 14
Chicago 12
Ningbo 12
Verona 12
Fairfield 10
Taizhou 10
A Coruña 8
Padova 8
Radomsko 7
Washington 7
Borås 6
Fuzhou 6
Guangzhou 6
Huizhou 6
Pune 6
Rome 6
Amman 5
Lanzhou 5
Auburn Hills 4
Colombo 4
Leawood 4
Livorno 4
London 4
Turin 4
Changchun 3
Florence 3
Haikou 3
Kashipur 3
Nanning 3
Orange 3
Palermo 3
Sofia 3
Sulaymaniyah 3
Walnut 3
Zapopan 3
Ancona 2
Barcelona 2
Canberra 2
Cernusco sul Naviglio 2
Delhi 2
Frankfurt am Main 2
Gwangjin-gu 2
Haifa 2
Ixelles-Elsene 2
Kolkata 2
Monmouth Junction 2
Naples 2
North Bergen 2
Novokuznetsk 2
Nuremberg 2
Omaha 2
Ottawa 2
Qingdao 2
Rockville 2
Sacramento 2
San Giuliano Milanese 2
Shubrā 2
Stockholm 2
São Paulo 2
Sèvres 2
Tappahannock 2
Taranto 2
Tokyo 2
Torino 2
Totale 6.895
Nome #
La sindrome oro-digito facciale tipo II. Studio clinico e cefalometrico di un caso 159
Central regulation of nasal cycle and magnetic resonance imaging of the brain in patients with Kallmann's syndrome 94
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 90
Role of Breast Ultrasonography in the Diagnosis of Precocious Puberty 86
Multicenter Study On Prevalence of Endocrine Complications In Thalassemia Major - Italian Working Group On Endocrine Complications In Non-endocrine Diseases 86
A novel nonsense mutation in the Pit-1 gene: evidence for a gene dosage effect. 85
Cytotoxic activity in GH-deficiency 81
Hyperthyroidism in children 80
Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. 79
Severe hyponatremia followed by extrapontine myelinolysis 79
Analysis of the factor affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. 78
Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism 77
Influence of growth hormone (GH) on natural killer (NK) activity in women with impaired endogenous growth hormone secretion 76
Androgen insensitivity syndrome (AIS): a histologic and morphometric study in prepubertal patients 76
Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness 74
Correlazione clinica tra taurodontismo e sindrome di Klinefelter 74
SHOX region mutation in Leri-Weill dischondrosteosis (LWS) 74
Increased insulin response to intravenous glucose tolerance test in girls with central precocious puberty 73
Mutational analysis in a group of patients with Noonan syndrome, new mutations identified in SOS1 73
Deficienze ed eccedenze ponderali 72
Linear growth according to the genotype of patients with Noonan syndrome 72
Auxologia 71
Cyproterone acetate treatment in precocious puberty 71
Pubertal development after bone marrow transplantation in adolescents. 69
Blood cell mitochondrial DNA content and premature ovarian aging 69
Biological activities of GH measured by Nb2 cell bioassay 69
Cisti ovariche dall'epoca fetale all'adolescenza 69
Prospective study of endocrine side-effects following bone marrow transplantation in childhood. 67
Effect of corticoid therapy on growth hormone secretion 66
Adrenarche in patients with central precocious puberty: Influence on growth parameters before and during GnRH-Analog therapy 66
Deficienze ed eccedenze staturali 66
Abnormal growth in Noonan syndrome: correlation between growth parameters and genotype 66
Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment. 65
Androgen insensivity syndrome (AIS): an histologic and morphometric study in prepubertal patients 65
Plasma leptin and its relationship with hormonal and metabolic parameters in girls with different forms of precocious puberty. 64
Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate 64
Plasma IGF-I, IGFII, IGFBPs and their relationship with urinary Gh excretion and growth in thalassemia major patients 64
Idiopathic central precocious puberty associated with 11 mb de novo distal deletion of the chromosome 9 short arm. 64
Adult height in children with short stature and idiopathic delayed puberty after different management. 63
La pubertà precoce: aspetti diagnostici e terapeutici 62
Alterazioni dello sviluppo puberale 62
Un caso familiare di sindrome di Noonan 62
Treatment of central precocious puberty, comparison between the leuprorelin 1-month (3.75 mg) and 3-month depot (11.25 mg) formulations 62
Auxological, clinical and neuroradiological findings in infants with early onset growth hormone deficiency. 62
Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. 61
Growth hormone evaluation in short and tall children: assay-dependent results 61
The influence of adrenarche on bone age and final height prediction of patients with central precocious puberty before and during GnRH analog therapy 61
Effect of biosynthetic methionyl growth hormone (GH) therapy on the immune function in GH-deficient children 61
Dissection of partial 21q monosomy in different phenotypes: clinical and molecular characterization of five cases and review of the literature 61
McCune-Albright syndrome: a longitudinal clinical study of 32 patients 60
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children 60
Transdermal Estradiol Substitution Therapy For Female Hypogonadism In Thalassemia Major 60
Final height (FH) in 77 patients af fected by constitutional delay of growth and puberty (CDGP) variously treated 60
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 60
Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. 59
Il trattamento della sindrome dell'ovaio policistico (PCOs) in età adolescenziale 59
La ragazza con sindrome di Turner che diventa adulta 59
Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism. 59
Pattern of inheritance and analysis of clinical and cerebral MRI features of familial cases of central precocious puberty 59
Final height of patients with constitutional delay in growth and puberty (CDGP) with or without transient GH deficiency. 59
Growth and growth hormone deficiency in hypogonadotropic hypogonadism and hypo/anosmia (Kallmann's syndrome) 58
Transdermal estradiol in female hypogonadism replacement therapy 58
Magnetic resonance imaging (MRI) in 28 infants with GH deficiency presenting before five years of age (EGHD) 58
Insulin-Dependent Diabetes Mellitus in Adolescents with ß-Thalassemia Major 58
Influence of biosynthetic growth hormone (GH) therapy on the immune system of GH-deficient children 57
Cryptic chromosomal deletions detected by array-CGH in four cases affected by central precocious puberty and neurodevelopmental disorders 57
Pharmachological Stimuli in the Diagnosis of Growth Hormone Deficiency: Pretreatment with Pyridostigmine 57
End results in central precocious puberty with GnRH analog treatment: the data of the italian study group for physiopathology of puberty. 56
Linear growth according to the genotype of patients with Noonan syndrome 56
L'abuso sessuale nei bambini prepuberi. Requisiti e raccomandazioni per una valutazione appropriata 56
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. 56
Comparison of bioactivity versus immunoactivity of serum growth hormone in children with growth disorders 56
L’impiego dela formulazione trimestrale di leuprorelina (11,25 mg) nel trattamento della pubertà precoce vera 56
Benzydamine for the topical treatment of vulvovaginitis in children and adolescents. 56
Etiology and age incident of precocious puberty in girls: a multicenter study. 55
Growth in pubertal children after bone marrow transplantation 55
Gonadal Function in adolescents after bone marrow transplantation 55
Patologie peculiari dell’apparato genitale 55
Serum Anti-Müllerian Hormone (AMH) and Inhibin (IB) levels in girls with isolated premature thelarche and with central precocious puberty 55
Growth promoting effect of long-term HCG and HU-FSH treatment in patients with hypogonadotropic hypogonadism 55
Induction of puberty with transdermal estradiol replacement therapy 55
Selecting girls with precocious puberty for brain imaging: Validation of European evidence-based diagnosis rule 55
Etiology of central precocious puberty in males: the results of the italian study group for physiopathology of puberty. 54
Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency 54
Immunological and endocrinological response to growth hormone therapy in short children 54
Pharmacological stimuli in diagnosis of growth hormone deficiency: pretreatment with pyridostigmine 54
Recombinant growth hormone treatment in short patients with thalassemia major: results after 24 and 36 months. 54
Recurrent abdominal pain and primary amenorrhea in an adolescent with plurimalformative syndrome 54
Comparison between short acting and long acting tratment for CPP: Final data 54
Molecular genetic analysis of 21-OH mutated HLA haplotypes in disorders of puberty 54
Effect of HCG on growth velocity and biological growth parameters in adolescents with thalassemia major 54
Reduced bone mineral density in patients with thalassemia major:comparison between spontaneous and hormonally induced puberty 54
Nk activity in GH deficiet children 54
Le precocità sessuali 54
The influence of parental origin of the extra X-chromosome on the somatic and neuro-behavioral(cognitive phenotype in a cohort of patients with Klinefelter sindrome. 54
L’infezione da Helicobacter Pylori in età pediatrica sembra favorire l’insorgenza di tiroiditi autoimmuni in soggetti HLA-DRB1*0301 positivi. 54
The influence of parental origin of the extra X-chromosome on the somatic and neuro-behavioral/cognitive phenotype in a cohort of patients with Klinefelter syndrome 53
Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. 53
Long-term follow-up of premature thelarche (PT) 53
Natural cytotoxicity and growth hormone treatment 53
Totale 6.408
Categoria #
all - tutte 38.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020669 0 0 0 0 0 181 12 176 5 221 66 8
2020/20211.555 176 139 62 153 7 213 3 205 64 246 225 62
2021/2022811 4 4 49 3 22 63 20 47 47 18 140 394
2022/20232.523 286 125 11 303 323 320 3 152 893 9 51 47
2023/2024696 90 118 19 75 79 178 5 74 4 21 19 14
2024/2025486 47 222 67 73 24 53 0 0 0 0 0 0
Totale 10.204